drugset / Trial / NCT00315081

Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine

NCT00315081

Phase 3 Unknown 20 enrolled University Hospital, Bonn
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Antipsychotic drugs can cause a clinically relevant hyperprolactinemia due to blocking the dopamine receptors in the pituitary.Schizophrenic patients suffering from a neuroleptic-induced hyperprolactinemia will be examined endocrinologically. Adverse drug effects and diagnoses will be confirmed by measuring hormones.

Timeline

Start
2006-05
Primary completion
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromocriptine Small molecule